These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19394790)

  • 1. Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence.
    Turner TH; LaRowe S; Horner MD; Herron J; Malcolm R
    J Subst Abuse Treat; 2009 Dec; 37(4):328-34. PubMed ID: 19394790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of amlodipine for cocaine dependence: a negative report.
    Malcolm R; LaRowe S; Cochran K; Moak D; Herron J; Brady K; Hedden S; Woolson R; Halushka P
    J Subst Abuse Treat; 2005 Mar; 28(2):197-204. PubMed ID: 15780550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive dysfunction in chronic cocaine users: an exploratory study.
    Madoz-Gúrpide A; Blasco-Fontecilla H; Baca-García E; Ochoa-Mangado E
    Drug Alcohol Depend; 2011 Aug; 117(1):55-8. PubMed ID: 21277707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological assessment of current and past crack cocaine users.
    De Oliveira LG; Barroso LP; Silveira CM; Sanchez ZV; De Carvalho Ponce J; Vaz LJ; Nappo SA
    Subst Use Misuse; 2009; 44(13):1941-57. PubMed ID: 20001290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence.
    Winhusen T; Somoza E; Ciraulo DA; Harrer JM; Goldsmith RJ; Grabowski J; Coleman FS; Mindrum G; Kahn R; Osman S; Mezinskis J; Li SH; Lewis D; Horn P; Montgomery MA; Elkashef A
    Drug Alcohol Depend; 2007 Dec; 91(2-3):141-8. PubMed ID: 17629631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled screening trial of celecoxib for the treatment of cocaine dependence.
    Reid MS; Angrist B; Baker S; Woo C; Schwartz M; Montgomery A; Majewska D; Robinson J; Rotrosen J
    Addiction; 2005 Mar; 100 Suppl 1():32-42. PubMed ID: 15730348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.
    Joffe H; Hall JE; Gruber S; Sarmiento IA; Cohen LS; Yurgelun-Todd D; Martin KA
    Menopause; 2006; 13(3):411-22. PubMed ID: 16735938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
    Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.
    Johnson BA; Roache JD; Ait-Daoud N; Javors MA; Harrison JM; Elkashef A; Mojsiak J; Li SH; Bloch DA
    Drug Alcohol Depend; 2006 Oct; 84(3):256-63. PubMed ID: 16631323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-regulation and treatment retention in cocaine dependent individuals: a longitudinal study.
    Verdejo-García A; Betanzos-Espinosa P; Lozano OM; Vergara-Moragues E; González-Saiz F; Fernández-Calderón F; Bilbao-Acedos I; Pérez-García M
    Drug Alcohol Depend; 2012 Apr; 122(1-2):142-8. PubMed ID: 22018602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin.
    Ehrenreich H; Hinze-Selch D; Stawicki S; Aust C; Knolle-Veentjer S; Wilms S; Heinz G; Erdag S; Jahn H; Degner D; Ritzen M; Mohr A; Wagner M; Schneider U; Bohn M; Huber M; Czernik A; Pollmächer T; Maier W; Sirén AL; Klosterkötter J; Falkai P; Rüther E; Aldenhoff JB; Krampe H
    Mol Psychiatry; 2007 Feb; 12(2):206-20. PubMed ID: 17033631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.